A phase I study of regional 5-fluorouracil and systemic folinic acid for patients with colorectal liver metastases.
A phase I study was undertaken in order to establish the maximum tolerated dose of intra-hepatic arterial 5-fluorouracil (5-FU) when given in combination with systemic folinic acid. Patients with colorectal liver metastases (n = 10) received escalating doses of 5-FU as a 24 h infusion with a fixed d...
Main Authors: | , , , |
---|---|
Format: | Online |
Language: | English |
Published: |
1992
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1977775/ |